Top

Published in:

Open Access 01-05-2010 | Statement

White paper on imaging biomarkers

Author: European Society of Radiology (ESR)

Published in: Insights into Imaging | Issue 2/2010

Abstract

Because of the importance of biomarkers within medicine as a whole and the increasing realisation that imaging can safely provide biomarkers, the ESR executive commissioned this report by experts in the field. It is hoped that further awareness amongst our community will contibute to further exploitation of the enormous wealth of biomaker information available in our day to day imaging. The all important issues surrounding validation and standardisation are discussed, together with proposals for a European Network on Imaging Biomarkers to oversee such aspects.

Biomarkers definitions working group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95CrossRef

Altar CA (2008) The biomarkers consortium: on the critical path of drug discovery. Clin Pharmacol Ther 83:361–364PubMedCrossRef

Hanahan D, Weinberg R (2000) The hallmarks of cancer. Cell 100:57–70PubMedCrossRef

Newell D (2003) The drug development process: from target discovery to the clinic. Clin Med 3:323–326CrossRef

Pepe M, Etzioni R, Feng Z, Potter J, Lou M (2001) Phases of biomarkers development for early detection of cancer. J Natl Cancer Inst 93:1054–1061PubMedCrossRef

Workman P, Aboagye E, Chung YL et al (2006) Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies. J Natl Cancer Inst 98:580–598PubMedCrossRef

Wells G (2009) Liver fibrosis: challenges of the new era. Gastroenterology 136:387–388PubMedCrossRef

Kelloff G, Sigman C (2005) New science-based endpoints to accelerate oncology drug development. Eur J Cancer 41:491–501PubMedCrossRef

Carden CP, Banerji U, Kaye SB, Workman P, De Bono JS (2009) From darkness to light with biomarkers in early clinical trials of cancer drugs. Clin Pharmacol Ther 85:131–133PubMedCrossRef

10.

Ritcher W (2006) Imaging biomarkers as surrogate endpoints for drug development. Eur J Nucl Med Mol Imaging 33:S6–S10

11.

Sargent DJ, Rubinstein L, Schwartz L et al (2009) Validation of novel imaging methodologies for use as cancer clinical trial end-points. Eur J Cancer 45:290–299PubMedPubMedCentralCrossRef

12.

Tofts PS, Brix G, Buckley DL et al (1999) Estimating kinetic parameters from dynamic contrast enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232PubMedCrossRef

13.

Leach MO, Brindle KM, Evelhoch JL et al (2005) The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Brit J Cancer 92:1599–1610PubMedPubMedCentralCrossRef

14.

Padhani AR, Liu G, Mu-Koh D et al (2009) Diffusion weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102–125PubMedPubMedCentralCrossRef

15.

Van Beers BE, Vilgrain V (2009) Biomarkers in abdominal imaging. Abdom Imaging 34:663–667PubMedCrossRef

16.

Buckler AJ, Mozley PD, Schwartz L et al (2010) Volumetric CT in lung cancer: an example for the qualification of imaging as a biomarker. Acad Radiol 17:107–115PubMedCrossRef

17.

Eisenhauser EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1). Eur J Cancer 45:228–247CrossRef

18.

Llovet JM, Di Bisceglie A, Bruix J et al (2008) Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100:698–711PubMedCrossRef

19.

European Medicines Agency (2007) Innovative drug development approaches. Final report from the EMEA/CHMP-Think-Tank group on innovative drug development. Doc.Ref.: EMEA/127318/2007 available at http://www.emea.europa.eu/pdfs/human/itf/12731807en.pdf

Title: White paper on imaging biomarkers
Author: European Society of Radiology (ESR)
Publication date: 01-05-2010
Publisher: Springer Berlin Heidelberg
Published in: Insights into Imaging / Issue 2/2010
Electronic ISSN: 1869-4101
DOI: https://doi.org/10.1007/s13244-010-0025-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

White paper on imaging biomarkers

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2010

Imaging in patients with breast implants—results of the First International Breast (Implant) Conference 2009

How often do patients ask for the results of their radiological studies?

An assessment of medical students’ awareness of radiation exposures associated with diagnostic imaging investigations

Research in cardiac radiology: a European Society of Radiology white paper

Computed tomography of complicated Meckel’s diverticulum in adults: a pictorial review

Radiology and primary care in Europe